Archive

This is my archive

Comments on D.P.U. 20-80, Investigation by the Department of Public Utilities on Its Own Motion into the Role of Gas Local Distribution Companies as the Commonwealth Achieves Its Target 2050 Climate Goals

On May 6, 2022, the Emmett Clinic filed comments to the Massachusetts Department of Public Utilities (DPU) proposing a framework for measuring equity in a way that considers the distribution of both the positive and negative impacts of transitioning to a decarbonized energy system.

May 06, 2022

Comments on Proposed Revocation of the 2020 Reconsideration, and Affirmation of the Appropriate and Necessary Supplemental Finding, 87 Fed. Reg. 7624 (Docket ID No. EPA-HQ-OAR-2018-0794)

On April 11, 2022, the Emmett Clinic submitted comments supporting the Environmental Protection Agency’s (EPA) proposal to reaffirm earlier findings underlying the agency’s regulation of mercury and other toxic air pollutant emissions from coal-fired power plants. The comments were filed on behalf of a group of leading scientific experts in…

April 11, 2022

Comments on D.P.U. 20-80, Investigation by the Department of Public Utilities on its Own Motion into the Role of Gas Local Distribution Companies as the Commonwealth Achieves its Target 2050 Climate Goals

In June 2021, the Clinic filed a comment letter on behalf of a group of Massachusetts municipalities and regional planning associations in the Department of Public Utility’s investigation regarding the role of local gas distribution companies in helping the Commonwealth achieve its 2050 net zero climate goal, which includes reducing…

June 14, 2021

Comments on Rescinding the Rule on “Increasing Consistency and Transparency in Considering Benefits and Costs in the Clean Air Act Rulemaking Process,” 86 Fed. Reg 26,406 (Docket ID No. EPA-HQ-OAR-2020-0044)

On June 14, 2021, the Clinic submitted comments on behalf of the Chesapeake Bay Foundation and National Parks Conservation Association supporting EPA’s decision to rescind the Trump-era regulation regarding the use of cost-benefit analyses in Clean Air Act rulemakings. The letter supported EPA’s conclusion that the rulemaking was unnecessary, unresponsive…

June 14, 2021

Comments on Proposed Interim Registration Review Decision for Chlorpyrifos and Revised Draft Human Health Risk Assessment, 85 Fed. Reg. 78,849

On February 5, 2021, the Clinic submitted a comment letter urging the Environmental Protection Agency (EPA) to reverse its proposed registration decision for chlorpyrifos and revise the underlying Human Health Risk Assessment (HHRA). The Clinic’s letter calls into question EPA’s decision to use 10% red blood cell acetyl cholinesterase (AChE)…

February 05, 2021

Comments On Proposed Rule: “Increasing Consistency and Transparency in Considering Benefits and Costs In The Clean Air Act Rulemaking Process,” 85 Fed. Reg 35,612, Docket ID No. EPA-HQ-OAR-2020-0044

On August 3, 2020, the Clinic submitted comments on behalf of the Chesapeake Bay Foundation and the National Parks Conservation Association on the Environmental Protection Agency’s Proposed Rule “Increasing Consistency and Transparency in Considering Benefits and Costs in the Clean Air Act Rulemaking Process.” The comments urge EPA to withdraw…

August 03, 2020